Delivering the Future of Vaccines With mRNA Technology

Delivering the Future of Vaccines With mRNA Technology

One of the great tools that helped turned the tide of the COVID-19 pandemic was the use of vaccines, especially those based on messenger RNA (mRNA) technology. Such vaccines use molecules that teach the cells in the body to generate proteins used by viruses or cancers, allowing the body’s immune system to recognize and fight off future infections.

read more

Pin It on Pinterest

Mount Sinai Today
Mount Sinai Receives Five-Year Grant to Support First-of-Its-Kind Translational Science Program for Nurses
Mount Sinai Researchers Publish First Genome-Wide Analysis of Binge Eating Disorder
Could Personalized PSA Levels Enhance Prostate Cancer Screening?
Here’s What to Know About the First Approved Pill Treatment for Postpartum Depression
AI Spotlight: Mapping Out Links Between Drugs and Birth Defects
Mount Sinai’s Role in Hemodialysis: From the First Treatment in the United States to Continuing Innovations
Mount Sinai Researchers Play a Prominent Role in a Wide Probe Into Long COVID
AI Spotlight: Guiding Heart Disease Diagnosis Through Transformer Models
Delivering the Future of Vaccines With mRNA Technology

Share This

Share this post with your friends!

Share This

Share this post with your friends!